Cubist Pharmaceuticals, Inc. (CBST) Reports Q1 EPS of $0.10
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
Cost of product revenues: 94.96M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Cost of product revenues: 94.96M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q1 EPS of $0.10, versus $0.34 reported last year. Revenue for the quarter came in at $261.2 million versus the consensus estimate of $285.24 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
